Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Repligen Sweden AB
AB
Active
Org 5568690704
Sankt Lars Väg 47, 222 70
Lund
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2011 · 14 years old
100-199 employees
Overvåg
Share
Sweden
/
Companies
/
Manufacture of basic pharmaceutical products
/
Repligen Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
245M
490M
736M
981M
452M
2020
683M
2021
725M
2022
853M
2023
588M
2024
EBITDA
SEK millions
725M
544M
363M
181M
0M
203M
2020
411M
+102%
2021
423M
+3%
2022
580M
+37%
2023
421M
-27%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
452 359
683 186
724 875
852 740
587 721
Staff expenses
—
—
—
—
—
EBITDA
203 367
411 166
423 298
580 163
420 600
Depreciation & amort.
—
—
—
—
—
EBIT
203 367
411 166
423 298
580 163
420 600
Net financials
−17 994
8 425
30 482
93 082
139 451
Profit before tax
192 562
419 618
453 784
673 256
560 058
Tax
−41 249
−86 765
−93 264
−138 743
−71 831
Net profit
151 313
332 853
360 520
534 513
488 227
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 240 300
929 013
1 297 259
2 555 986
3 364 923
Equity
988 842
678 695
1 039 215
1 663 895
2 152 122
Long-term debt
192 048
186 003
186 003
806 856
948 808
Short-term debt
59 258
64 315
72 041
85 235
47 068
Total debt
251 306
250 318
258 044
892 091
995 876
Financial ratios
5-year trend
EBITDA-margin
71.6%
This company
15.8%
Market median
+353% vs market
2020
2024
Soliditetsgrad
64.0%
This company
38.2%
Market median
+68% vs market
2020
2024
Egenkapitalforrentning
22.7%
This company
18.4%
Market median
+23% vs market
2020
2024
Nettoresultatgrad
83.1%
This company
8.1%
Market median
+926% vs market
2020
2024
Aktivomsætning
0.17×
This company
1.12×
Market median
-85% vs market
2020
2024
Gæld/egenkapital
0.56×
This company
0.62×
Market median
+10% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Repligen Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
